Skip to Content

Omnicell Inc OMCL

Morningstar Rating
$27.35 −0.17 (0.62%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OMCL is trading at a 731% premium.
Price
$27.60
Fair Value
$49.95
Uncertainty
Very High
1-Star Price
$91.53
5-Star Price
$38.62
Economic Moat
Jfmkx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OMCL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$27.52
Day Range
$27.1727.80
52-Week Range
$25.1669.26
Bid/Ask
$27.24 / $27.48
Market Cap
$1.26 Bil
Volume/Avg
63,630 / 489,091

Key Statistics

Price/Earnings (Normalized)
17.75
Price/Sales
1.13
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Value
Total Number of Employees
3,590

Competitors

Valuation

Metric
OMCL
MCK
CAH
Price/Earnings (Normalized)
17.7521.1013.27
Price/Book Value
1.06
Price/Sales
1.130.250.11
Price/Cash Flow
10.0217.729.85
Price/Earnings
OMCL
MCK
CAH

Financial Strength

Metric
OMCL
MCK
CAH
Quick Ratio
1.860.500.42
Current Ratio
2.380.920.98
Interest Coverage
15.5714.23
Quick Ratio
OMCL
MCK
CAH

Profitability

Metric
OMCL
MCK
CAH
Return on Assets (Normalized)
3.15%5.63%4.01%
Return on Equity (Normalized)
6.00%
Return on Invested Capital (Normalized)
3.19%64.13%97.71%
Return on Assets
OMCL
MCK
CAH
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GE HealthCare Technologies Inc Common Stock
GEHC
KxyjfrcnQnq$37.0 Bil
Veeva Systems Inc Class A
VEEV
FtvkspqvCbfw$29.2 Bil
Solventum Corp
SOLV
Hvrgv$9.5 Bil
Pro Medicus Ltd
PMCUF
Whzjdb$9.2 Bil
M3 Inc
MTHRF
Bgwhbp$6.9 Bil
M3 Inc ADR
MTHRY
Cgkbxwj$6.9 Bil
HealthEquity Inc
HQY
Fckfnm$6.8 Bil
Tempus AI Inc Class A common stock
TEM
Fmsr$6.6 Bil
R1 RCM Inc
RCM
Jzp$5.4 Bil
Doximity Inc Class A
DOCS
Gjdmyg$5.1 Bil

Sponsor Center